The RD‐Connect Genome‐Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases

Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the wide adoption of next‐generation sequencing. However, many cases remain undiagnosed even after exome or genome analysis, because the methods used missed the molecular cause in a known gene, or a novel causative gene could not be identified and/or confirmed. To address these challenges, the RD‐Connect Genome‐Phenome Analysis Platform (GPAP) facilitates the collation, discovery, sharing, and analysis of standardized genome‐phenome data within a collaborative environment. Authorized clinicians and researchers submit pseudonymised phenotypic profiles encoded using the Human Phenotype Ontology, and raw genomic data which is processed through a standardized pipeline. After an optional embargo period, the data are shared with other platform users, with the objective that similar cases in the system and queries from peers may help diagnose the case. Additionally, the platform enables bidirectional discovery of similar cases in other databases from the Matchmaker Exchange network. To facilitate genome‐phenome analysis and interpretation by clinical researchers, the RD‐Connect GPAP provides a powerful user‐friendly interface and leverages tens of information sources. As a result, the resource has already helped diagnose hundreds of rare disease patients and discover new disease causing genes.

[1]  Danielle R Azzariti,et al.  Seven years since the launch of the Matchmaker Exchange: The evolution of genomic matchmaking , 2022, Human mutation.

[2]  K. Doheny,et al.  The impact of GeneMatcher on international data sharing and collaboration , 2022, Human mutation.

[3]  Orion J. Buske,et al.  PhenomeCentral: 7 years of rare disease matchmaking , 2021, Human mutation.

[4]  M. Hurles,et al.  DECIPHER: Supporting the interpretation and sharing of rare disease phenotype‐linked variant data to advance diagnosis and research , 2021, Human mutation.

[5]  P. Chinnery,et al.  High diagnostic rate of trio exome sequencing in consanguineous families with neurogenetic diseases , 2021, Brain : a journal of neurology.

[6]  J. Gécz,et al.  Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. , 2021, American journal of human genetics.

[7]  L. Garavelli,et al.  Clinical Manifestations in a Girl with NAA10-Related Syndrome and Genotype–Phenotype Correlation in Females , 2021, Genes.

[8]  Pieter B. T. Neerincx,et al.  Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases , 2021, European Journal of Human Genetics.

[9]  L. Vissers,et al.  A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis , 2021, European Journal of Human Genetics.

[10]  Pieter B. T. Neerincx,et al.  Solving patients with rare diseases through programmatic reanalysis of genome-phenome data , 2021, European Journal of Human Genetics.

[11]  I. Nelson,et al.  Exome reanalysis and proteomic profiling identified TRIP4 as a novel cause of cerebellar hypoplasia and spinal muscular atrophy (PCH1) , 2021, European Journal of Human Genetics.

[12]  Z. Qin,et al.  Clinical application of whole-exome sequencing: A retrospective, single-center study , 2021, Experimental and therapeutic medicine.

[13]  Pieter B. T. Neerincx,et al.  Solving unsolved rare neurological diseases—a Solve-RD viewpoint , 2021, European Journal of Human Genetics.

[14]  A. Nordgren,et al.  Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients , 2021, Genome Medicine.

[15]  Julius O. B. Jacobsen,et al.  Interpretable prioritization of splice variants in diagnostic next-generation sequencing , 2021, bioRxiv.

[16]  Christopher G Chute,et al.  The Human Phenotype Ontology in 2021 , 2020, Nucleic Acids Res..

[17]  Astrid Gall,et al.  Ensembl 2021 , 2020, Nucleic Acids Res..

[18]  I. Gut,et al.  Improved Diagnosis of Rare Disease Patients through Systematic Detection of Runs of Homozygosity , 2020, The Journal of molecular diagnostics : JMD.

[19]  P. Stenson,et al.  The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting , 2020, Human Genetics.

[20]  B. Bender,et al.  Confirmation of TACO1 as a Leigh Syndrome Disease Gene in Two Additional Families , 2020, Journal of neuromuscular diseases.

[21]  L. Pérez-Jurado,et al.  Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum , 2020, Orphanet journal of rare diseases.

[22]  A. Evangelista,et al.  A single nucleotide deletion resulting in a frameshift in exon 4 of TAB2 is associated with a polyvalular syndrome. , 2020, European journal of medical genetics.

[23]  S. Beltran,et al.  COL4A1-related autosomal recessive encephalopathy in 2 Turkish children , 2020, Neurology: Genetics.

[24]  Melissa J. Landrum,et al.  ClinVar: improvements to accessing data , 2019, Nucleic Acids Res..

[25]  F. Sanz,et al.  The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..

[26]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[27]  Katherine R. Smith,et al.  PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels , 2019, Nature Genetics.

[28]  S. Bernasconi,et al.  Alazami syndrome: the first case of papillary thyroid carcinoma , 2019, Journal of Human Genetics.

[29]  D. MacArthur,et al.  Severe neurodevelopmental disease caused by a homozygous TLK2 variant , 2019, European Journal of Human Genetics.

[30]  A. Olry,et al.  Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database , 2019, European Journal of Human Genetics.

[31]  Matthew S. Lebo,et al.  Analyzing and Reanalyzing the Genome: Findings from the MedSeq Project. , 2019, American journal of human genetics.

[32]  M. Mora,et al.  Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI , 2019, Neuromuscular Disorders.

[33]  Birgit Funke,et al.  Best practices for benchmarking germline small-variant calls in human genomes , 2019, Nature Biotechnology.

[34]  David Haussler,et al.  Federated discovery and sharing of genomic data using Beacons , 2019, Nature Biotechnology.

[35]  Alexandros Kouris,et al.  VarSome: the human genomic variant search engine , 2018, bioRxiv.

[36]  M. Gut,et al.  Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness , 2018, American journal of medical genetics. Part A.

[37]  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS , 2018, British Medical Journal.

[38]  Damian Smedley,et al.  The 100 000 Genomes Project: bringing whole genome sequencing to the NHS , 2018, British Medical Journal.

[39]  L. Garavelli,et al.  A Novel CCND2 Mutation in a Previously Reported Case of Megalencephaly and Perisylvian Polymicrogyria with Postaxial Polydactyly and Hydrocephalus. , 2018, Neuropediatrics.

[40]  Rachel Thompson,et al.  RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases , 2018, European Journal of Human Genetics.

[41]  David R. FitzPatrick,et al.  Paediatric genomics: diagnosing rare disease in children , 2018, Nature Reviews Genetics.

[42]  Tomas W. Fitzgerald,et al.  Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1133 families with developmental disorders , 2017, Genetics in Medicine.

[43]  Christine M. Cutillo,et al.  Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective , 2017, Clinical and translational science.

[44]  Mauricio O. Carneiro,et al.  Scaling accurate genetic variant discovery to tens of thousands of samples , 2017, bioRxiv.

[45]  Tudor Groza,et al.  Matchmaker Exchange , 2017, Current protocols in human genetics.

[46]  A. Philippakis,et al.  International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases , 2017, American journal of human genetics.

[47]  Marcella Attimonelli,et al.  HmtDB 2016: data update, a better performing query system and human mitochondrial DNA haplogroup predictor , 2016, Nucleic Acids Res..

[48]  Christopher P Austin,et al.  ‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases , 2016, European Journal of Human Genetics.

[49]  Simon Heath,et al.  From Wet‐Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome Sequencing , 2016, Human mutation.

[50]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[51]  B. Knoppers,et al.  International Charter of principles for sharing bio-specimens and data , 2016, European Journal of Human Genetics.

[52]  Y. Parman,et al.  Novel mutations in genes causing hereditary spastic paraplegia and Charcot-Marie-Tooth neuropathy identified by an optimized protocol for homozygosity mapping based on whole-exome sequencing , 2015, Genetics in Medicine.

[53]  G. McVean,et al.  A reference data set of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree , 2016, bioRxiv.

[54]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[55]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[56]  Damian Smedley,et al.  Next-generation diagnostics and disease-gene discovery with the Exomiser , 2015, Nature Protocols.

[57]  Chris Mungall,et al.  The Matchmaker Exchange API: Automating Patient Matching Through the Exchange of Structured Phenotypic and Genotypic Profiles , 2015, Human mutation.

[58]  Orion J. Buske,et al.  The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.

[59]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[60]  Arcadi Navarro,et al.  The European Genome-phenome Archive of human data consented for biomedical research , 2015, Nature Genetics.

[61]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[62]  Tomas W. Fitzgerald,et al.  Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.

[63]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[64]  A. F. Scott,et al.  OMIM.org: Online Mendelian Inheritance in Man , 2015 .

[65]  P. Robinson,et al.  RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research , 2014, Journal of General Internal Medicine.

[66]  M. Bowman What is a Mosaic , 2014 .

[67]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[68]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[69]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[70]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[71]  Hai Hu,et al.  Assessing semantic similarity measures for the characterization of human regulatory pathways , 2006, Bioinform..

[72]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[73]  D. Cooper,et al.  Human Gene Mutation Database , 1996, Human Genetics.